Generics
Teva Provides Update on Fremanezumab Clinical Development for Use in Episodic Cluster Headache
24 April 2019 - - Israeli drugmaker Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) has provided an update that the company is discontinuing the clinical development program for use of f...
Teva Launches Generic Version of VESIcare Tablets in the United States
24 April 2019 - - Israeli drugmaker Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) has launched a generic version of VESIcare 1 (solifenacin succinate) Tablets, 5 mg and 10 mg...
Teva Pharmaceutical begins US launch of generic VESIcare tablets
24 April 2019 - Israel-based Teva Pharmaceutical Industries Ltd (NYSE and TASE: TEVA) has launched a generic version of VESIcare (solifenacin succinate) Tablets, 5mg and 10mg, in the United States, it...
Oakrum Pharma signs product development and commercialisation partnership with Biophore
23 April 2019 - Biopharmaceutical company Oakrum Pharma LLC revealed on Monday the launch of an agreement to develop and manufacture two prescription generic pharmaceutical products to be commercialis...
Teva Pharmaceutical launches generic version of VESIcare tablets in the US
23 April 2019 - Teva Pharmaceutical Industries Ltd (Teva) (TASE:TEVA) (HYSE:TEVA) announced on Monday the launch of a generic version of VESIcare 1 (solifenacin succinate) tablets, 5 mg and 10 mg, in ...
Phyton Biotech and AqVida receive European approval for paclitaxel injectable FDF
23 April 2019 - Phyton Biotech, a German/North American Plant Cell Fermentation technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) manufacturer, have received European...